G9129 Onc diagnosis mult myeloma stg2 hig
Also known as: multiple myeloma stage 2 high risk, intermediate multiple myeloma
Oncology diagnosis for multiple myeloma stage 2 with high-risk features.
In Plain Language
intermediate stage multiple myeloma; high-risk multiple myeloma
Clinical Context
Documentation of multiple myeloma patients with stage 2 disease and adverse prognostic factors, requiring aggressive induction therapy.
RVU Information
CPT G9129 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code G9129?
CPT G9129 (Onc diagnosis mult myeloma stg2 hig) is a G Codes code. Oncology diagnosis for multiple myeloma stage 2 with high-risk features.
Who uses CPT code G9129?
CPT G9129 is used by Hematologic Oncology, Medical Oncology, Hematology. Documentation of multiple myeloma patients with stage 2 disease and adverse prognostic factors, requiring aggressive induction therapy.
When is CPT G9129 used?
Documentation of multiple myeloma patients with stage 2 disease and adverse prognostic factors, requiring aggressive induction therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.